Ceribell, Inc.

Ceribell, Inc. (CBLL) priced its initial public offering on Oct 11, 2024 at $17.00 per share, within its $16.00–$17.00 range, raising $180.3M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $578.3M. BofA Securities was lead-left underwriter, joined by J.P. Morgan, William Blair and TD Cowen and others. A&O Shearman advised the underwriters.

Ceribell, Inc. is a commercial-stage medical technology company that developed the Ceribell System, a point-of-care electroencephalography platform pairing portable hardware with AI algorithms for diagnosing and monitoring patients with neurological conditions in acute care settings.

Status

IPO

Ticker

CBLL

Exchange

Nasdaq Global Select

Priced

Oct 11, 2024

IPO price

$17.00

Price range

$16.00–$17.00

Raised

$180.3M

Market cap at IPO price

$578.3M

First filed

Aug 26, 2024

Underwriters

BofA Securities, J.P. Morgan, William Blair, TD Cowen and Canaccord Genuity

Underwriters' counsel

A&O Shearman

Sector

Healthcare

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.